{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:56:17Z","timestamp":1792626977103,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL137995"],"award-info":[{"award-number":["1R01HL137995"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL152735-01"],"award-info":[{"award-number":["1R01HL152735-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.chest.2021.01.004","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T17:03:21Z","timestamp":1610298201000},"page":"2244-2253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Protein Biomarkers for COPD Outcomes"],"prefix":"10.1016","volume":"159","author":[{"given":"Karina A.","family":"Serban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Pratte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell P.","family":"Bowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.chest.2021.01.004_bib1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S2213-2600(16)00094-1","article-title":"Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective","volume":"4","author":"Han","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.chest.2021.01.004_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1165\/rcmb.2018-0245PS","article-title":"Omics and the search for blood biomarkers in chronic obstructive pulmonary disease. Insights from COPDGene","volume":"61","author":"Regan","year":"2019","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.chest.2021.01.004_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1741-7015-11-181","article-title":"Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease","volume":"11","author":"Wedzicha","year":"2013","journal-title":"BMC Med"},{"issue":"5","key":"10.1016\/j.chest.2021.01.004_bib4","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1378\/chest.12-1489","article-title":"Efficacy of roflumilast in the COPD frequent exacerbator phenotype","volume":"143","author":"Wedzicha","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.chest.2021.01.004_bib5","series-title":"BEST (Biomarkers, EndpointS, and other Tools) Resource","year":"2016"},{"issue":"2","key":"10.1016\/j.chest.2021.01.004_bib6","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.bbrc.2014.07.086","article-title":"Integrative genomics of chronic obstructive pulmonary disease","volume":"452","author":"Hobbs","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.chest.2021.01.004_bib7","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s41588-018-0342-2","article-title":"Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations","volume":"51","author":"Sakornsakolpat","year":"2019","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.chest.2021.01.004_bib8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2213-2600(19)30056-6","article-title":"Early-onset emphysema in a large French-Canadian family: a genetic investigation","volume":"7","author":"Bosse","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.chest.2021.01.004_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1378\/chest.129.1.151","article-title":"Reduced histone deacetylase in COPD: clinical implications","volume":"129","author":"Barnes","year":"2006","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.chest.2021.01.004_bib10","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1172\/JCI69636","article-title":"Histone deacetylase 6-mediated selective autophagy regulates COPD-associated cilia dysfunction","volume":"123","author":"Lam","year":"2013","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.chest.2021.01.004_bib11","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1165\/rcmb.2013-0304OC","article-title":"DNA methylation is globally disrupted and associated with expression changes in chronic obstructive pulmonary disease small airways","volume":"50","author":"Vucic","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"12","key":"10.1016\/j.chest.2021.01.004_bib12","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1513\/AnnalsATS.201710-770WS","article-title":"New strategies and challenges in lung proteomics and metabolomics. An Official American Thoracic Society Workshop Report","volume":"14","author":"Bowler","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"8","key":"10.1016\/j.chest.2021.01.004_bib13","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1164\/rccm.201302-0247OC","article-title":"Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease","volume":"188","author":"Cheng","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2021.01.004_bib14","doi-asserted-by":"crossref","first-page":"17132","DOI":"10.1038\/s41598-018-35372-w","article-title":"Metabolomics and transcriptomics pathway approach reveals outcome-specific perturbations in COPD","volume":"8","author":"Cruickshank-Quinn","year":"2018","journal-title":"Sci Rep"},{"issue":"suppl","key":"10.1016\/j.chest.2021.01.004_bib15","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1513\/AnnalsATS.201306-204AW","article-title":"Significance of the microbiome in chronic obstructive pulmonary disease","volume":"10","author":"Martinez","year":"2013","journal-title":"Ann Am Thorac Soc"},{"issue":"10","key":"10.1016\/j.chest.2021.01.004_bib16","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1164\/rccm.201806-1135OC","article-title":"Sputum microbiome is associated with 1-year mortality after chronic obstructive pulmonary disease hospitalizations","volume":"199","author":"Leitao Filho","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.chest.2021.01.004_bib17","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa021322","article-title":"The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease","volume":"350","author":"Celli","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.chest.2021.01.004_bib18","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1378\/chest.06-0702","article-title":"Development and validation of an improved, COPD-specific version of the St. George Respiratory Questionnaire","volume":"132","author":"Meguro","year":"2007","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.chest.2021.01.004_bib19","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1183\/09031936.02.02092001","article-title":"Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease","volume":"20","author":"Troosters","year":"2002","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.chest.2021.01.004_bib20","doi-asserted-by":"crossref","first-page":"W460","DOI":"10.2214\/AJR.12.10102","article-title":"Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease","volume":"201","author":"Schroeder","year":"2013","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.chest.2021.01.004_bib21","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1183\/09031936.04.00014304","article-title":"Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS\/ERS position paper","volume":"23","author":"Celli","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2021.01.004_bib22","first-page":"537","article-title":"Hypo-alpha-1-antitrypsinemia [in German]","volume":"70","author":"Laurell","year":"1964","journal-title":"Verh Dtsch Ges Inn Med"},{"issue":"3","key":"10.1016\/j.chest.2021.01.004_bib23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/thx.2003.006502","article-title":"Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk","volume":"59","author":"DeMeo","year":"2004","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.chest.2021.01.004_bib24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41588-018-0321-7","article-title":"New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries","volume":"51","author":"Shrine","year":"2019","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.chest.2021.01.004_bib25","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/thoraxjnl-2014-205507","article-title":"The path to personalised medicine in COPD","volume":"69","author":"Agusti","year":"2014","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.chest.2021.01.004_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12931-017-0631-9","article-title":"Using omics approaches to understand pulmonary diseases","volume":"18","author":"Kan","year":"2017","journal-title":"Respir Res"},{"issue":"10","key":"10.1016\/j.chest.2021.01.004_bib27","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1164\/rccm.201810-1860SO","article-title":"Chronic obstructive pulmonary disease biomarkers and their interpretation","volume":"199","author":"Stockley","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.chest.2021.01.004_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201900278","article-title":"Comparison of proteomic assessment methods in multiple cohort studies","volume":"20","author":"Raffield","year":"2020","journal-title":"Proteomics"},{"issue":"1","key":"10.1016\/j.chest.2021.01.004_bib29","doi-asserted-by":"crossref","first-page":"14248","DOI":"10.1038\/s41598-017-14755-5","article-title":"Assessment of variability in the SOMAscan assay","volume":"7","author":"Candia","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.chest.2021.01.004_bib30","first-page":"97","article-title":"Subtyping chronic obstructive pulmonary disease using peripheral blood proteomics","volume":"4","author":"Zarei","year":"2017","journal-title":"Chronic Obstr Pulm Dis"},{"issue":"3","key":"10.1016\/j.chest.2021.01.004_bib31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1164\/rccm.201803-0402OC","article-title":"Albuminuria, lung function decline, and risk of incident chronic obstructive pulmonary disease. The NHLBI Pooled Cohorts Study","volume":"199","author":"Oelsner","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.chest.2021.01.004_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046207","article-title":"Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputum","volume":"7","author":"Ropcke","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.chest.2021.01.004_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2019-000449","article-title":"Complications and discomfort after research bronchoscopy in the MicroCOPD study","volume":"7","author":"Leiten","year":"2020","journal-title":"BMJ Open Respir Res"},{"issue":"18","key":"10.1016\/j.chest.2021.01.004_bib34","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.2147\/COPD.S75978","article-title":"Protein networks in induced sputum from smokers and COPD patients","volume":"10","author":"Baraniuk","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"18","key":"10.1016\/j.chest.2021.01.004_bib35","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1002\/elps.201300020","article-title":"Proteomic analysis of human epithelial lining fluid by microfluidics-based nanoLC-MS\/MS: a feasibility study","volume":"34","author":"Franciosi","year":"2013","journal-title":"Electrophoresis"},{"issue":"2","key":"10.1016\/j.chest.2021.01.004_bib36","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1378\/chest.08-1583","article-title":"Proteomic analysis in lung tissue of smokers and COPD patients","volume":"135","author":"Lee","year":"2009","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2021.01.004_bib37","doi-asserted-by":"crossref","first-page":"e5043","DOI":"10.1371\/journal.pone.0005043","article-title":"Comparison of proteomic and transcriptomic profiles in the bronchial airway epithelium of current and never smokers","volume":"4","author":"Steiling","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.chest.2021.01.004_bib38","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jprot.2015.08.009","article-title":"Alterations in the sputum proteome and transcriptome in smokers and early-stage COPD subjects","volume":"128","author":"Titz","year":"2015","journal-title":"J\u00a0Proteomics"},{"issue":"10","key":"10.1016\/j.chest.2021.01.004_bib39","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1164\/rccm.200906-0857OC","article-title":"Identification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive pulmonary disease","volume":"181","author":"Nicholas","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.chest.2021.01.004_bib40","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1164\/rccm.201010-1623OC","article-title":"Identification of novel diagnostic biomarkers for asthma and chronic obstructive pulmonary disease","volume":"183","author":"Verrills","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.chest.2021.01.004_bib41","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/thx.2006.064428","article-title":"Profiling serum biomarkers in patients with COPD: associations with clinical parameters","volume":"62","author":"Pinto-Plata","year":"2007","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.chest.2021.01.004_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1378\/chest.07-0058","article-title":"Systemic inflammation and COPD: the Framingham Heart Study","volume":"133","author":"Walter","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.chest.2021.01.004_bib43","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1465-9921-12-146","article-title":"COPD association and repeatability of blood biomarkers in the ECLIPSE cohort","volume":"12","author":"Dickens","year":"2011","journal-title":"Respir Res"},{"issue":"3","key":"10.1016\/j.chest.2021.01.004_bib44","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jaci.2012.09.024","article-title":"Gender differences in the bronchoalveolar lavage cell proteome of patients with chronic obstructive pulmonary disease","volume":"131","author":"Kohler","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.chest.2021.01.004_bib45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/15412555.2013.831063","article-title":"Analysis of the plasma proteome in COPD: novel low abundance proteins reflect the severity of lung remodeling","volume":"11","author":"Merali","year":"2014","journal-title":"COPD"},{"issue":"1","key":"10.1016\/j.chest.2021.01.004_bib46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12931-017-0597-7","article-title":"Multiple biomarkers predict disease severity, progression and mortality in COPD","volume":"18","author":"Zemans","year":"2017","journal-title":"Respir Res"},{"issue":"1","key":"10.1016\/j.chest.2021.01.004_bib47","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12931-017-0662-2","article-title":"The value of blood cytokines and chemokines in assessing COPD","volume":"18","author":"Bradford","year":"2017","journal-title":"Respir Res"},{"key":"10.1016\/j.chest.2021.01.004_bib48","first-page":"A6136","article-title":"The proteomic profile associated with lung function and COPD in the Jackson Heart Study","volume":"201","author":"Ngo","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2021.01.004_bib49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12931-014-0127-9","article-title":"The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes","volume":"15","author":"Carolan","year":"2014","journal-title":"Respir Res"},{"issue":"2","key":"10.1016\/j.chest.2021.01.004_bib50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S2213-2600(13)70006-7","article-title":"The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study","volume":"1","author":"Coxson","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.chest.2021.01.004_bib51","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1164\/rccm.200705-678OC","article-title":"Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease","volume":"177","author":"Bozinovski","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2021.01.004_bib52","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1164\/rccm.201607-1330OC","article-title":"Biomarkers predictive of exacerbations in the SPIROMICS and COPDGene cohorts","volume":"195","author":"Keene","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2021.01.004_bib53","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1183\/09031936.00111707","article-title":"Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)","volume":"31","author":"Vestbo","year":"2008","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2021.01.004_bib54","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3109\/15412550903499522","article-title":"Genetic epidemiology of COPD (COPDGene) study design","volume":"7","author":"Regan","year":"2010","journal-title":"COPD"},{"key":"10.1016\/j.chest.2021.01.004_bib55","first-page":"2011","article-title":"Tesra (treatment Of Emphysema With A Selective Retinoid Agonist) Study Results","volume":"183","author":"Jones","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2021.01.004_bib56","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1055\/s-0035-1555609","article-title":"The Promise of Observational Studies (ECLIPSE, SPIROMICS, and COPDGene) in achieving the goal of personalized treatment of chronic obstructive pulmonary disease","volume":"36","author":"Rennard","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.chest.2021.01.004_bib57","first-page":"204","article-title":"Serum proteins associated with emphysema progression in severe alpha-1 antitrypsin deficiency","volume":"4","author":"Beiko","year":"2017","journal-title":"Chronic Obstr Pulm Dis"},{"issue":"10","key":"10.1016\/j.chest.2021.01.004_bib58","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1513\/AnnalsATS.201503-143OC","article-title":"Rationale and design of the genomic research in alpha-1 antitrypsin deficiency and sarcoidosis study. Alpha-1 protocol","volume":"12","author":"Strange","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.chest.2021.01.004_bib59","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1021\/pr800545q","article-title":"Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group","volume":"8","author":"Tuck","year":"2009","journal-title":"J\u00a0Proteome Res"},{"issue":"11","key":"10.1016\/j.chest.2021.01.004_bib60","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201910427","article-title":"Plasma proteome profiling to detect and avoid sample-related biases in biomarker studies","volume":"11","author":"Geyer","year":"2019","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.chest.2021.01.004_bib61","doi-asserted-by":"crossref","unstructured":"Rikkert LG, Coumans FAW, Hau CM, Terstappen L, Nieuwland R. Platelet removal by single-step centrifugation [published online ahead of print June 17, 2020]. Platelets. https:\/\/doi.org\/10.1080\/09537104.2020.1779924.","DOI":"10.1080\/09537104.2020.1779924"},{"issue":"23","key":"10.1016\/j.chest.2021.01.004_bib62","doi-asserted-by":"crossref","first-page":"E5390","DOI":"10.1073\/pnas.1714813115","article-title":"Mistimed food intake and sleep alters 24-hour time-of-day patterns of the human plasma proteome","volume":"115","author":"Depner","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.chest.2021.01.004_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016021","article-title":"Gender differences in plasma biomarker levels in a cohort of COPD patients: a pilot study","volume":"6","author":"de Torres","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.chest.2021.01.004_bib64","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1475-097X.2008.00795.x","article-title":"Enhanced exercise-induced plasma cytokine response and oxidative stress in COPD patients depend on blood oxygenation","volume":"28","author":"Jammes","year":"2008","journal-title":"Clin Physiol Funct Imaging"},{"issue":"121","key":"10.1016\/j.chest.2021.01.004_bib65","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1183\/09059180.00004311","article-title":"Night-time symptoms: a forgotten dimension of COPD","volume":"20","author":"Agusti","year":"2011","journal-title":"Eur Respir Rev"},{"issue":"6","key":"10.1016\/j.chest.2021.01.004_bib66","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1164\/rccm.201509-1722PP","article-title":"Plasma fibrinogen qualification as a drug development tool in chronic obstructive pulmonary disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium","volume":"193","author":"Miller","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2021.01.004_bib67","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1081\/COPD-200050513","article-title":"St. George's Respiratory Questionnaire: MCID","volume":"2","author":"Jones","year":"2005","journal-title":"COPD"},{"issue":"3","key":"10.1016\/j.chest.2021.01.004_bib68","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1172\/JCI6092","article-title":"Quantum proteolysis by neutrophils: implications for pulmonary emphysema in alpha 1-antitrypsin deficiency","volume":"104","author":"Campbell","year":"1999","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.chest.2021.01.004_bib69","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1378\/chest.06-2251","article-title":"Measurements of desmosine and isodesmosine by mass spectrometry in COPD","volume":"131","author":"Ma","year":"2007","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.chest.2021.01.004_bib70","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1476-5381.2012.01984.x","article-title":"RAGE: a new frontier in chronic airways disease","volume":"167","author":"Sukkar","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"22","key":"10.1016\/j.chest.2021.01.004_bib71","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1056\/NEJMoa1909159","article-title":"Diagnosis of pulmonary embolism with d-Dimer adjusted to clinical probability","volume":"381","author":"Kearon","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.chest.2021.01.004_bib72","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamacardio.2016.0962","article-title":"Association of elevated plasma endothelin-1 levels with pulmonary hypertension, mortality, and heart failure in african american individuals: the Jackson Heart Study","volume":"1","author":"Jankowich","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"8","key":"10.1016\/j.chest.2021.01.004_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006011","article-title":"Common genetic polymorphisms influence blood biomarker measurements in COPD","volume":"12","author":"Sun","year":"2016","journal-title":"PLoS Genet"},{"issue":"7708","key":"10.1016\/j.chest.2021.01.004_bib74","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","article-title":"Genomic atlas of the human plasma proteome","volume":"558","author":"Sun","year":"2018","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.chest.2021.01.004_bib75","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/metabo10040124","article-title":"Identifying protein-metabolite networks associated with COPD phenotypes","volume":"10","author":"Mastej","year":"2020","journal-title":"Metabolites"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236922100026X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236922100026X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:34:09Z","timestamp":1757925249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001236922100026X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S001236922100026X"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2021.01.004","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein Biomarkers for COPD Outcomes","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2021.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}